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Abstract 
Oligodendrocytes (OLs) are in many ways im-
plicated in the pathophysiology of schizophrenia. 
However, very little is currently known about possible 
OL cell cycle disturbances in schizophrenia, a phe-
nomenon which has been described for the birth of 
new hippocampal neurons in schizophrenics. When 
morphometrically analyzing the density of prohibitin-
expressing OLs in diff erent prefrontal white matter 
areas of patients with schizophrenia, we found a sig-
nifi cantly increased density of this OL subpopulation 
in the anterior cingulate cortex. Prohibitin is a mito-
chondrial protein, which is expressed both in neurons 
and OLs. Among many other functions, this protein 
plays an important role in the control of cell prolifera-
tion and apoptosis by regulating the GTPase OPA1. 
Hence, out data might be taken as possible hint for 
disease-related cell cycle abnormalities. 
Introduction
To the key fi ndings in the neuropathology of 
schizophrenia belong decreases in OL density as well 
an altered spatial distribution, deviant cell morphol-
ogy and protein expression patterns of these cells, 
which manifest themselves in an impaired chemical 
composition of myelin, abberant communication be-
tween diff erent brain regions and other white matter 
abnormalities (reviewed in refs. 1 and 2). Th e reasons 
for reduced OL number and myelin-specifi c gene ex-
pression impariments in schizophrenia are yet poorly 
understood. When analysing what signalling path-
ways may elicit these defi cits, Katsel et al.1 found that 
especially genes associated with canonical cell cycle 
pathways were aff ected in the anterior cingulate gyrus 
(ACG), the region exhibiting the most profound my-
elin-specifi c gene expression changes in schizophre-
nia. Th us, while almost all other studies have focused 
on seeking abnormalities that impede OL maturation 
at the level of migration, myelination, and survival1,2, 
the results of Katsel ś group3. provide the fi rst experi-
mental evidence that not only neurons, but also OLs 
(or, more precisely, OL progenitor cells), may suff er 
from cell cycle disturbances in schizophrenia. 
Our group has recently shown that the neuronal 
expression of prohibitin is upregulated in schizophre-
nia, which might be an indication of disease-related 
synaptic pathology4. Subsequent analysis revealed that 
the protein is also abundantly expressed in white mat-
ter OLs5. Emerging evidence in favour of a prominent 
role of prohibitin in the control of cell cycle (ref. 6 and 
others) encouraged us to analyse the OL expression 
of prohibitin in diff erent brain white matter areas pa-
tients with schizophrenia.
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Material and methods
All brains were obtained from Magdeburg brain 
bank. Brains of six individuals with clinically con-
fi rmed schizophrenia and seven matched controls 
without neurological or psychiatric disorders were 
studied.  Th e tissue preparation was as described ear-
lier7. 
Prohibitin immunoreactivity was detected with 
a monoclonal antibody using the nickel-enhanced 
avdin-biotin technique4. Prohibitin is present in mul-
tiple mature OLs as well as in progenitor cells located 
in the subventricular zone. Th e density of prohibitin-
expressing OLs was determined in left and right dor-
solateral prefrontal cortex, anterior cingulate cortex, 
and orbitofrontal cortex as recently described8. 
Results
Qualitatively, probibitin was found to be ex-
pressed in a majority of white matter OLs and some 
gray matter OLs. Th e intracellular immunostaining 
was confi ned to granule-like organelles, which were 
distributed within the cytoplasm and are most prob-
ably mitochondria. Prohibitin-immunoreactive cells 
were also observed in the subventricular zone. Mor-
phometrically, a signifi cant (p=0.035) increase in the 
numerical density of prohibitin immunoreactive OLs 
was found in the right dorsolateral prefrontal cortex. 
In all other brain areas under study no diff erences be-
tween schizophrenics and controls were seen. A limi-
tation of this study is the small number of cases.
Discussion
Although a nuclear localization of prohibitin has 
also been reported, there is yet consensus that this 
protein is predominantly localized to the mitochon-
dria, where it might have roles in the maintenance of 
mitochondrial morphology and  function, protection 
against senescence, tumor suppression, apoptosis and 
the regulation of cell-cycle progression6,9. Previously, 
the latter function was seriously questioned, because 
it is hard to imagine how a mitochondrial protein 
might manage this. A recent paper has convincingly 
shown that mitochondria-located prohibitin is indeed 
capable of controlling cell cycle by coupling cell pro-
liferation to mitochondrial morphogenesis through 
the GTPase OPA16. Th us, the observed increased 
expression of the anti-proliferative protein prohibitin 
in dorsolateral prefrontal OLs might well be part of 
a disturbed signalling cascade which fi nally leads to 
an Ol impaired cell cycle activity in schizophrenia3. 
However, since prohibitin  is involved in a plethora 
of diff erent regulatory mechanisms, our data cannot 
be taken as an evidence for this, and further studies 
are clearly needed to learn more about  OL cell cycle 
abnormalities in schizophrenia. Th erefore, studies are 
in progress to co-stain prohibitin with the prolifera-
tion marker Ki67.
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